Natixis Advisors LLC Raises Stock Holdings in Cabot Co. (NYSE:CBT)

Natixis Advisors LLC raised its stake in Cabot Co. (NYSE:CBT - Free Report) by 7.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 124,079 shares of the specialty chemicals company's stock after buying an additional 8,068 shares during the period. Natixis Advisors LLC owned about 0.23% of Cabot worth $11,330,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. First Horizon Advisors Inc. lifted its stake in shares of Cabot by 22.0% in the 3rd quarter. First Horizon Advisors Inc. now owns 650 shares of the specialty chemicals company's stock valued at $73,000 after purchasing an additional 117 shares during the period. GAMMA Investing LLC lifted its stake in shares of Cabot by 10.7% in the 4th quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock valued at $123,000 after purchasing an additional 130 shares during the period. Personal CFO Solutions LLC lifted its stake in shares of Cabot by 3.3% in the 4th quarter. Personal CFO Solutions LLC now owns 4,285 shares of the specialty chemicals company's stock valued at $391,000 after purchasing an additional 137 shares during the period. Moran Wealth Management LLC lifted its stake in shares of Cabot by 0.3% in the 3rd quarter. Moran Wealth Management LLC now owns 62,116 shares of the specialty chemicals company's stock valued at $6,943,000 after purchasing an additional 178 shares during the period. Finally, Isthmus Partners LLC lifted its stake in shares of Cabot by 4.8% in the 4th quarter. Isthmus Partners LLC now owns 4,072 shares of the specialty chemicals company's stock valued at $372,000 after purchasing an additional 187 shares during the period. Institutional investors own 93.18% of the company's stock.

Remove Ads

Cabot Stock Down 0.5 %

CBT stock traded down $0.38 during trading on Friday, reaching $82.17. 996,165 shares of the stock were exchanged, compared to its average volume of 350,589. The firm has a market cap of $4.46 billion, a P/E ratio of 10.91, a price-to-earnings-growth ratio of 0.74 and a beta of 1.21. Cabot Co. has a twelve month low of $79.57 and a twelve month high of $117.46. The firm's 50 day moving average is $86.38 and its 200 day moving average is $98.75. The company has a current ratio of 2.00, a quick ratio of 1.29 and a debt-to-equity ratio of 0.72.

Cabot (NYSE:CBT - Get Free Report) last posted its earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, beating analysts' consensus estimates of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. As a group, research analysts forecast that Cabot Co. will post 7.57 EPS for the current year.

Cabot declared that its board has authorized a share buyback plan on Tuesday, December 3rd that authorizes the company to repurchase 10,000,000 outstanding shares. This repurchase authorization authorizes the specialty chemicals company to reacquire shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's leadership believes its shares are undervalued.

Cabot Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were issued a $0.43 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.09%. Cabot's dividend payout ratio is presently 22.84%.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on CBT shares. JPMorgan Chase & Co. dropped their price objective on Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a research note on Friday, February 21st. Mizuho dropped their price target on Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a research note on Tuesday, January 7th. Finally, StockNews.com downgraded Cabot from a "buy" rating to a "hold" rating in a research note on Tuesday, March 11th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, Cabot has an average rating of "Hold" and an average price target of $97.00.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.